SELLAS Life Sciences
30 hedge funds and large institutions have $17.1M invested in SELLAS Life Sciences in 2021 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 11 increasing their positions, 6 reducing their positions, and 6 closing their positions.
144% more call options, than puts
Call options by funds: $3.19M | Put options by funds: $1.31M
83% more repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 6
33% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 6
3% more funds holding
Funds holding: 29 → 30 (+1)
0.86% less ownership
Funds ownership: 12.58% → 11.72% (-0.86%)
20% less capital invested
Capital invested by funds: $21.3M → $17.1M (-$4.18M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$1.57M |
| 2 |
Bank of America
Charlotte,
North Carolina
|
+$407K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$304K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$301K |
| 5 |
SFI
Susquehanna Fundamental Investments
Bala Cynwyd,
Pennsylvania
|
+$263K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JG
Jefferies Group
New York
|
-$1.67M |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$1.17M |
| 3 |
Marshall Wace
London,
United Kingdom
|
-$938K |
| 4 |
EGM
Engineers Gate Manager
New York
|
-$309K |
| 5 |
SGI
Summit Global Investments
Bountiful,
Utah
|
-$127K |
SLS Hedge Fund Activity: Q3 2021 in Review
30 of the 5,728 institutional investors tracked by Wall St. Rank reported a position in SELLAS Life Sciences (SLS) for Q3 2021, worth a combined $17.1M — down 20% from $21.3M a quarter earlier.
Buyers outnumbered sellers: 8 funds opened new SLS positions and 6 closed out — a net gain of 2 holders — while 11 added to existing stakes and 6 trimmed.
The largest buyer was Morgan Stanley, adding an estimated $1.57M. The largest seller was Jefferies Group, exiting entirely with an estimated $1.67M sold.
- 30 institutional investors held SELLAS Life Sciences (SLS) as of Q3 2021, up from 29 in Q2 2021.
- Funds reported $17.1M of SELLAS Life Sciences stock for Q3 2021, down 20% quarter-over-quarter.
- 8 funds opened new SELLAS Life Sciences positions in Q3 2021 and 6 closed out, a net change of +2 holders.
- The largest SELLAS Life Sciences buyer in Q3 2021 was Morgan Stanley, an estimated $1.57M added.
- The largest SELLAS Life Sciences seller in Q3 2021 was Jefferies Group, an estimated $1.67M sold.
Based on aggregated 13F filings for Q3 2021.